Stepan to Announce Third Quarter 2026 Results on October 28, 2026

Stepan Company (NYSE: SCL) will release its Q3 2026 earnings on October 28, 2026, at 7:00 a.m. ET, with a conference call at 9:00 a.m. ET. The company manufactures specialty chemicals for various industries. Its stock is traded on the NYSE under the symbol SCL.

Original reporting
Published Oct 7, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 11:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Stepan to Announce Third Quarter 2026 Results on October 28, 2026 — source image
Decision brief

The 30-second read

$SCLNeutralLow
01

Why it matters

The announcement provides a concrete date for traders to plan pre‑earnings positioning. No new financial data is disclosed, so the immediate impact is limited to timing awareness.

02

Market read

A routine earnings‑release schedule with limited immediate trading relevance; primary interest for traders is timing the upcoming Q3 results.

03

What to watch

Analysts may already have expectations for Q3; the real catalyst will be the earnings numbers themselves.

Relevance 4/10Novelty 3/10Timing: pre‑market on Oct 28, 2026

Background

Stepan Company (NYSE: SCL) is a specialty chemicals manufacturer. The press release sets the schedule for its Q3 2026 earnings call.

Company-level read

Ticker impact

$SCLNeutralMedium confidence
Context

Stepan Company announced the date and time of its Q3 2026 earnings release and conference call.

Expected impact

potential short‑term price swing around the release, direction depends on earnings surprise

Evidence & confidence

No financial numbers are disclosed yet; the news is purely a timing announcement, so impact is speculative.

Market effects

None significant; the announcement is specific to Stepan and does not affect the broader chemicals sector.

Limited to U.S. investors tracking Stepan; no broader regional effect.

Minimal, as the news is a routine earnings schedule.

Counterpoint

If the market overreacts to the timing announcement, a contrarian could look for a short‑term pullback after the release.

Key entities

  • Stepan Company

    Specialty chemicals producer announcing Q3 2026 earnings release.

  • Luis E. Rojo

    President and CEO of Stepan, will host the earnings call.

  • Ruben Velasquez

    Senior Vice President and CFO of Stepan, will co‑host the earnings call.

Related articles

$SCLMed

Stepan Co (SCL) (Q3 2026) Earnings Call Highlights: 7% Organic Volume Growth

Stepan Co (SCL) reported Q3 2026 earnings with 7% organic volume growth and 18% year-over-year adjusted EBITDA increase to $66.3M. Project Catalyst savings exceeded targets, and net leverage improved. Dividends increased for the 59th consecutive year. Challenges include weak polymer volumes in Europe and Asia, rising raw material costs, and a regulatory maintenance turnaround in Germany.

$SCLHighAI 8/10

Stepan (SCL) Q3 2026 Earnings Call Transcript

Stepan (SCL) reported Q3 2026 earnings with adjusted EBITDA up 18% YoY to $66.3M, driven by volume growth and margin recovery. Net income rose 64% to $17.8M. Sales increased across surfactants, polymers, and specialty products. Project Catalyst savings exceeded expectations. Management cited geopolitical risks and rising raw material costs as challenges.

$SCLMedAI 8/10

Stepan Company Q3 2026 Earnings Call Summary

Stepan Company reported Q3 2026 earnings with 7% organic volume growth, driven by North American polymers and surfactants. Margin recovery was sustained through pricing actions and cost offsets. Project Catalyst savings reached $23M quarterly, with expectations to exceed $25M in 2027. The company anticipates full-year 2026 adjusted EBITDA growth, positive free cash flow, and balance sheet deleveraging. Net leverage improved to 2.4x from 2.7x year-over-year.

$SCLMed

Stepan Q3 Earnings Call Highlights

Stepan Company (NYSE: SCL) reported Q3 net sales up 12% to $27M, with adjusted EBITDA rising 5% to $11.7M. Management cited higher volume in MCT products and cost pressures from volatile oil markets. Project Catalyst savings exceeded expectations, with $23M quarterly savings and $66M-$70M expected for 2026. Net debt reduced to $536M, and the dividend was raised by 2.5%.

$SCLMedAI 8/10

Stepan Q3 2026 slides: EPS doubles on volume growth, restructuring

Stepan Company (SCL) reported Q3 2026 adjusted EPS of $0.94, up 98% YoY, driven by 7% volume growth and restructuring savings. Revenue and EPS beat estimates. Shares rose 2.42%. Adjusted EBITDA increased 18% to $66.3M. Project Catalyst restructuring is ahead of schedule, with $23M quarterly savings. Net leverage ratio improved to 2.4x. Free cash flow was $8M, impacted by working capital build.